Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.
about
Establishment of a Flexible Real-Time Polymerase Chain Reaction-Based Platform for Detecting Prevalent Deafness Mutations Associated with Variable Degree of Sensorineural Hearing Loss in Koreans.Panel based MALDI-TOF tumour profiling is a sensitive method for detecting mutations in clinical non small cell lung cancer tumour.Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective techniquec-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients.BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens.Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trialNovel Approach for Clinical Validation of the cobas KRAS Mutation Test in Advanced Colorectal CancerDiagnostic RAS mutation analysis by polymerase chain reaction (PCR).Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer.KRAS Mutation Test in Korean Patients with Colorectal Carcinomas: A Methodological Comparison between Sanger Sequencing and a Real-Time PCR-Based Assay.KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond.A new generation of companion diagnostics: cobas BRAF, KRAS and EGFR mutation detection tests.Judging pathological assessment in cancer specimens.454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples.Anti-EGFR Therapy for Metastatic Colorectal Cancer in the Era of Extended RAS Gene Mutational Analysis.KRAS and BRAF genotyping of synchronous colorectal carcinomas.Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the pieEprobe-mediated screening system for somatic mutations in the KRAS locus.The times have changed: molecular pathology is here to stay. A commentary on: analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma,Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.Rapid and accurate detection of KRAS mutations in colorectal cancers using the isothermal-based optical sensor for companion diagnostics.Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice.
P2860
Q30373865-0B7EB088-CC87-4568-B690-6006AB7A9830Q33793611-E3A37678-69E3-4838-8667-20CBCC88C274Q34690590-E181B340-59BC-4777-A3D1-3309D24D02C5Q35721438-32FF37E1-645C-42FD-A384-E877DF6D9309Q35795297-2F3C5FC5-FE2D-4E87-8CD0-1CCD5D945022Q35877954-2DCF12D5-A8E7-4A6A-A9E6-0253155B15FAQ35905048-43F117E7-F71F-4B0A-B48B-D239DA03C2B4Q35962621-E2FF710E-9D1E-4F70-8EEA-39149BF3AF2CQ36089983-FD632BB5-E6E8-4506-A7E5-BAC35A10491DQ36228534-7CF77F84-007F-48BB-A821-2F758623567BQ36932799-AC314A1A-E32F-4201-9F7C-F0B53F354DAFQ37000019-79F68222-8F17-4B92-B377-E7CD6AA0765FQ37231968-83E3FF3B-1DDA-4A54-924B-DC1BF8C22923Q37607965-5629EF30-5C93-4B3E-AC8E-DD5F8C389AD1Q38136134-652C9C54-3FC2-4729-9D37-3AACA9FC0FB1Q38213074-4319DA7F-BB90-44C0-BE3D-14D7582CC46AQ38240804-84DDD4B2-479E-4B13-A5D1-B124F403A4E8Q38395259-D5334FDC-BD4C-4E6F-8D0E-328B9B9232FDQ38755440-8AF1DD09-3F23-4A87-A8D1-BA94AF6A900FQ38932624-CDEA759D-7203-4017-A4B4-CE200774F2FFQ39172118-9F0237F5-CDC9-403C-8CE0-CB0BFA99A60FQ40652551-0055375F-85CE-432F-A4EF-520A2819E58AQ42175961-D1338F50-860F-4235-BAD2-2B88A67F6131Q44193651-7DCA2A0B-34DA-4C6C-A30F-8FCC6EEEB058Q47139907-3AF866B8-4739-4FC7-92F4-3DCCC896F482Q55083559-4274081C-4795-4B7C-A0D1-D3D23988C924
P2860
Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Analytical performance of a PC ...... mples of colorectal carcinoma.
@en
Analytical performance of a PCR assay for the detection of KRAS mutations
@nl
type
label
Analytical performance of a PC ...... mples of colorectal carcinoma.
@en
Analytical performance of a PCR assay for the detection of KRAS mutations
@nl
prefLabel
Analytical performance of a PC ...... mples of colorectal carcinoma.
@en
Analytical performance of a PCR assay for the detection of KRAS mutations
@nl
P2093
P2860
P1433
P1476
Analytical performance of a PC ...... mples of colorectal carcinoma.
@en
P2093
Corey Hoeppner
H Jeffrey Lawrence
Jianli Cao
Margot Velez
Stephen Soviero
Victoria H Brophy
P2860
P2888
P304
P356
10.1007/S00428-011-1180-0
P577
2011-12-16T00:00:00Z
P5875
P6179
1002259545